Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes — Stella

Home/Diabetes Mellitus, Type 2/

View on ClinicalTrials.gov

Recruiting

Back to Diabetes Mellitus, Type 2 trials

Trial locations(1 site)

South Korea

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

Key details

Sponsor

Chong Kun Dang Pharmaceutical

Enrollment target

~10,000 participants

Started

March 2024

Primary completion

December 2026

Age range

19 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.